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The neuropeptide oxytocin plays a critical role in social cognition and behavior. A number
of studies using intranasal administration have demonstrated that oxytocin improves
social perception. However, little is known about the relationship between individual
differences in endogenous levels of oxytocin and social cognition. In the current study,
we assessed the relationship between endogenous oxytocin and brain activity during an
animacy perception paradigm. Thirty-seven male participants underwent scanning and
provided a blood sample for oxytocin analysis. In line with previous research, perception
of animacy was associated with activations in superior temporal sulcus, inferior frontal
gyrus, and medial prefrontal cortex (mPFC). Notably, participants’ levels of plasma
oxytocin robustly predicted activation in areas critical for social cognitive processes, such
that higher oxytocin levels were related to increased activity in dorsal mPFC, ventral
mPFC, dorsolateral PFC, superior temporal gyrus, and temporoparietal junction (TPJ),
suggesting differential processing of social stimuli. Together these results show that
stable variations in endogenous oxytocin levels explain individual differences in social
perception.
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Introduction
There is growing interest in understanding social cognition from the level of individual biology.
Differences in an individual’s ability to perceive, interpret, and act upon social information is
well-established in populations whose social deficits are a hallmark of their disorder (e.g., autism,
schizophrenia). Interest in establishing the biological roots of these disorders have resulted in the
use of endogenous, molecular predictors (e.g., genes, hormones) to explain variations in behavior
and provide a mechanistic explanation for these social deficits. It is unclear, however, how the
range of social cognitive variability in healthy populations might be explained by these same
biologically-based predictors. The current study attempts to validate a biomarker that predicts
individual differences in social cognition in healthy (neurotypical) participants.
One such candidate biomarker is oxytocin (OT), a neuropeptide important for pair bonding
and prosocial behaviors. Recent attention has been devoted to intranasal administration
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of OT and its effects on social cognition. Intranasal OT
promotes prosociality by increasing trust (Kosfeld et al., 2005),
generosity/reciprocity (Zak et al., 2007), and one’s ability to infer
mental states from nonverbal cues (Domes et al., 2007; Guastella
et al., 2010). Moreover, OT administration also improves social
perceptual processing such as enhancing recognition of facial
expressions (Marsh et al., 2010) and increasing sensitivity to
biological motion (Kéri and Benedek, 2009).
While the link between OT administration and social
cognition is becoming clear, the role of endogenous OT has
been largely ignored. An increasing number of double-blind,
random control trials are being conducted to assess how behavior
and cognition are modulated by exogenous OT administration
(MacDonald et al., 2011), but fewer studies leverage individual
variability in plasma OT levels to understand how behavior and
cognition are affected in the natural environment. Considerable
interindividual variability in endogenous OT levels exists:
plasma OT levels are heritable (Rubin et al., 2014) and show
remarkable stability over time. Feldman and colleagues (Feldman
et al., 2007) assessed plasma OT levels in individuals at
multiple time points over 6--9 months and obtained within-
subject correlations of r = 0.92--r = 0.96. On shorter time
scales, OT levels are also sensitive to contexts and have been
shown to be modulated by social interactions (Feldman et al.,
2010).
Importantly, endogenous levels of OT are also predictive of
social behavior. Of the endogenous OT studies that exist, a
number have shown positive relationships between plasma OT
and affiliative parenting styles (Gordon et al., 2010), prosocial
interactions with one’s romantic partner (Gouin et al., 2010),
trust (Zhong et al., 2012), and secure attachment styles (Tops
et al., 2007). A key question, however, is whether plasma
OT levels are similarly predictive of basic social cognitive
functioning. Low plasma levels have been observed in clinical
populations with marked social deficits, such as in autism
(Modahl et al., 1998), and greater OT levels have been associated
with more positive social outcomes, such as in schizophrenia
(Rubin et al., 2010). Recent work suggests that this relationship
may transcend clinical borders (Parker et al., 2014) and
that endogenous OT levels support the socio-emotional and
perceptive abilities essential for social cognition (Atzil et al.,
2012). We aim to directly test this association in a sample of
healthy adults.
The current study uses functional neuroimaging to probe
subtle variability in social cognition that might not be captured
in overt behavior. In a neurotypical population, performance
on social cognitive tasks is often at ceiling. Many of the
promotional effects of OT administration on social cognition
have been observed only when proficiency on the task at
hand is low, either due to autism-related deficits (Guastella
et al., 2010) or to individual differences in social proficiency
(Bartz et al., 2010). A recent report by Parker and colleagues
observed that plasma OT is associated with social function
in young children regardless of disease or risk status for
disease (Parker et al., 2014); however, the associations between
OT and behavior in the control group were modest and the
significant relationship was likely driven by the added variability
in social function provided by sampling from both healthy
children and those with autism. Given the restricted range in
performance in healthy populations, traditional measures are
less suitable for drawing associations with biological predictors.
In comparison, variations in neural activity have greater
sensitivity and can be observed in the absence of behavioral
differences; for instance, Kaiser et al. (2010) demonstrated similar
neural signatures for people with autism and their unaffected
siblings. While both groups shared a genetic susceptibility
to autism observable at the neural level, this susceptibility
was not adequately captured using behavioral measures.
Moreover, functional neuroimaging has also proven useful in
understanding the impact of intranasal OT administration on
social cognition (see Bethlehem et al., 2013 for a comprehensive
review).
In this study we used fMRI in concert with a task where
participants view films of geometric shapes interacting in an
animate fashion, a variation on Heider and Simmel’s classic
paradigm (Heider and Simmel, 1944). Because participants
spontaneously attribute mental states to these shapes, this
task reliably elicits activations in a network of brain regions
important for social cognition and perception, including
the medial prefrontal cortex (mPFC), superior temporal
sulcus, temporoparietal junction (TPJ), temporal poles, and
the fusiform gyrus (FG; Castelli et al., 2000, 2002; Schultz
et al., 2003). Performance on this task has been shown
to be affected in people with autism, with children with
autism providing fewer mental state attributions (Abell et al.,
2000), and adults with autism showing reduced brain activity
in regions described above (Castelli et al., 2002). This
pattern of deficits allows us to make predictions about
variability in healthy populations. Based on our prediction that
plasma OT levels could serve as a valid biomarker of social
cognitive functioning in healthy individuals, we hypothesized
that higher plasma OT levels would predict greater brain
activity in this task, specifically in regions supporting social
cognition.
Materials and Methods
Participants
Forty males (aged 18--29) participated in this experiment
prior to September 2013 as part of a larger imaging genetics
study. Participants were majority Caucasian, with 2 African
American, 2 East Asian participants, and 2 biracial participants
(Black/White, Hispanic/White). Participants also completed
a blood draw and a set of questionnaires for the larger
study, and were paid $50. Informed consent was obtained
from all participants according to the guidelines set by the
Health Sciences Institutional Review Board at the University
of Virginia. Three participants’ data were excluded1 from
analyses (all Caucasian) due to high (>2--4 SD) OT levels,
leaving 37 participants for the main analysis (mean age =
23.69).
1An alternate treatment of extreme OT values is log-transformation. We
include a summary of these results in the Supplementary Data section.
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Plasma Oxytocin
To minimize temporal variability, 8 ml of blood was collected
from participants between 10:00--11:00 am in a BDTM P100 blood
collection tube (BDDiagnostics, Franklin Lakes, NJ). These tubes
contain proprietary stabilizers that solubilize immediately upon
blood collection which prevents peptide degradation during
collection and at other downstream timepoints. Samples were
centrifuged within 1 h of collection per the manufacturer’s
protocol. The plasma was aliquoted by milliliter into cryotubes,
frozen overnight at−20◦C and then stored indefinitely at−80◦C.
In 2011, one tube from the first 28 samples was sent to the
laboratory of Sue Carter, then at the University of Illinois in
Chicago for analysis; in 2013 the same 28 samples and an
additional 12 samples were sent to the laboratory of Sue Carter,
now at the University of North Carolina.
OT levels were measured using a commercially available
enzyme immunoassay (EIA: Enzo Life Sciences Inc.,
Farmingdale, NY), which is sensitive (minimal detection
levels> 12 pg/ml OT) and specific with cross-reactivity between
OT and AVP < 0.04% (Rubin et al., 2014). Direct measurement
of OT was performed following the manufacturer’s protocols
and samples were diluted 1:2 as described previously (Kramer
et al., 2004). Samples were not extracted prior to analysis, as
extraction has been shown to precipitate the majority of the
OT in the blood (Martin and Carter, 2013). Samples were
assayed blind to subject information and all samples used in
analysis were run at the same time. OT plasma levels ranged
from 124.1 to 1483.6 pg/ml, with a mean of 365.35 (SD =
248.97). After removing the three outliers (range: 895.5--1483.6
pg/ml), the new mean was 307.28 (SD = 122.61). The inter-
and intra-assay coefficients of variability were 1.19% and
14.54%, respectively. Samples that were run 2 years apart
in two different lab settings correlated at Pearson’s r = 0.98
indicating remarkable stability of the samples and reliability of
the assay.
Validation of this EIA procedure has been described in
(Carter et al., 2007) and repeated in several laboratories in
studies in plasma from humans (e.g., Feldman et al., 2007, 2010;
Gordon et al., 2010; Gouin et al., 2010; Rubin et al., 2014),
nonhuman primates, rats and voles (Kramer et al., 2004). Tests
for parallelism have been conducted using serial dilutions of
plasma. Accuracy has been assessed by spiking samples with
standards of known concentrations of oxytocin. Specificity of the
antibody in the Assay Designs EIA kit was previous validated by
our group using high pressure liquid chromatography (for data
and details, see Carter et al., 2007).
Social Cognition Task
Video stimuli were adapted from (Schultz et al., 2003) and
included 15 s clips of geometric shapes interacting in a goal-
oriented (Animate condition) or random fashion (Random
condition). Each condition consisted of 8 clips (16 total),
interleaved with a jittered intertrial interval of approximately
1 s. In total, each run lasted 3 min and 56 s. Participants
were asked to actively attend to the video clips, but were
not given any additional instructions. Verbal confirmation
immediately pre- and post-run ensured participants were actively
attending to the task. Online monitoring of eye movements
between scan volumes served as another confirmation of
attentiveness.
Imaging Acquisition and Analysis
Participants were scanned using a Siemens Magnetom Trio 3T
MRI scanner and 12-channel head coil. A t1-weighted gradient-
echo structural image (MPRAGE ; TR = 1900 ms; TE = 2/53;
FOV = 250 mm; resolution = 1× 1× 1 mm) was acquired at the
beginning of the scan, followed by the T2*-weighted echo-planar
(EPI) functional images (TR = 2000 ms; TE = 40 ms; resolution =
3× 3× 4.2 mm; flip angle = 90 degrees; 28 slices), coplanar with
the structural image. A total of 128 functional brain volumes were
acquired.
Imaging analysis was conducted using GLM models in FSL
v5.0 (FMRIB software).2 Preprocessing steps included motion-
correction, brain extraction, coregistration to each participant’s
structural scan, spatial smoothing with a Gaussian kernel
of 5 mm FWHM, grand-mean intensity normalization, and
normalization into standard (Montreal Neurological Institute
(MNI)) space. Each subject’s first level linear model was
created using 15 s timecourses for each of the Animate and
Random conditions convolved with a standard gamma HRF
function. For the contrast of Animate-Random, a contrast of
parameter estimates (COPE) was computed for all subjects.
These individual COPEs were then used in the higher level group
models.
Two mixed-effects group models were constructed. First,
a main effect of group activation for the Animate-Random
contrast was computed to identify brain regions that were reliably
activated by the task. Additionally, we investigated the role of
plasma OT as a predictor of neural activity in the Animate-
Random contrast; OT levels were demeaned and added to the
GLM as a predictor. A whole-brain analysis was conducted. Z
(Gaussianised T) statistic images were thresholded using clusters
determined by Z > 2.3 and a corrected cluster significance
threshold of p< 0.05 (Worsley, 2001). Because our analysis with
OT is novel and somewhat exploratory, we did not conduct an
a priori region-of-interest analysis, but instead relied solely on a
more conservative whole-brain analysis.
Results
Our primary analysis focused on whether OT can predict
activation differences in brain regions sensitive to perception
of animate relative to random motion. Plasma OT was
entered into our model as a predictor and task-related
activations were computed with and without OT as
predictor. Figure 1 (blue clusters) and Table 1, panel A
show clusters of activity derived from the initial model of
mean group activation for the Animate-Random contrast.
Consistent with prior research (Castelli et al., 2000; Schultz
et al., 2003), the task elicited activity in lateral occipital
regions extending into the superior temporal gyrus and
ventrally into the fusiform. Also active were lateral frontal
2www.fmrib.ox.ac.uk/fsl
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FIGURE 1 | Clusters representing positive activations from the Animate
vs. Random contrast from whole-brain analysis with cluster
thresholding. Activations in blue represent positive task-related activity for
Animate relative to Random motion trials. Activations in red represent regions
that show a significant relationship between level of plasma OT and positive
task-related activity for Animate relative to Random motion trials.
regions, including inferior frontal gyrus extending into the
frontal poles.
The effects of plasma OT as a predictor of neural
activity for the Animate-Random contrast are illustrated in
Figure 1 (red clusters) and described in Table 1, panel
B. After modeling OT as a predictor in our whole-brain
analysis, five large (all >300 voxels) significant clusters were
identified, located in regions previously identified to be
critical to social cognitive processes: dorsal medial prefrontal
cortex (dmPFC), ventromedial prefrontal cortex (vmPFC),
left TPJ/angular gyrus extending into the left lateral cortex,
left dorsolateral prefrontal cortex (dlPFC) extending medially
into the paracingulate, and left middle/superior temporal
gyrus (STS). To demonstrate the direction of the relationship
between OT and brain activity, we registered these significant
clusters back to participants’ native space, extracted values for
the Animate-Random contrast and plotted them against OT
levels. As seen in Figure 2, these relationships are positive,
indicating that participants whose OT levels were higher had
greater brain activity for Animate displays than for Random
displays.
Discussion
As predicted, the current results revealed that plasma OT is
associated with greater activity in brain regions critical to
social cognition such as mentalizing, experience-sharing, and
empathy (Zaki and Ochsner, 2012). Previous work by Tavares
and colleagues (Tavares et al., 2008) has shown that neural
activity within a similar task is modulated via selective attention,
such that directing one’s attention toward the social aspects
of this task (i.e., mental state attributions) engages the ‘‘social
brain’’ to a greater extent than directing attention toward its
physical aspects (i.e., the spatial properties of the stimuli). While
TABLE 1 | Regions demonstrating greater BOLD response to Animate vs. Random displays.
Contrast Region Hemisphere x y z Z k
A. Group mean
STS/lateral occipital/fusiform R 30 −98 −6 7.77 8926
L −32 −94 −6 7.71 4481
IFG/frontal poles R 48 24 16 5.85 3621
L −50 24 16 4.62 1099
SPL/Angular gyrus R 30 −50 38 3.53 322
B. OT Predictor
dlPFC L −40 18 46 4.60 1114
M/STS L −56 −28 −18 4.51 769
dmPFC medial −14 64 22 4.61 623
TPJ/angular gyrus L −46 −72 42 4.14 491
vmPFC medial −6 52 −20 3.74 344
Legend: Table 1 reports the locations of peak voxels for significant clusters, p < 0.05, corrected for multiple comparisons. Coordinates are presented in MNI space; k =
number of voxels. Panel A represents regions that are significantly activated for the Animate-Random contrast. Panel B represents regions within the Animate-Random
contrast that are significantly predicted by modeling OT levels as a continuous predictor. STS = superior temporal sulcus; IFG = inferior frontal gyrus; SPL = superior
parietal lobule; dlPFC = dorsolateral prefrontal cortex; M/STS = middle/superior temporal sulcus; dmPFC = dorsomedial prefrontal cortex; TPJ = temporoparietal junction;
vmPFC = ventromedial prefrontal cortex.
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FIGURE 2 | Average BOLD signal values (Z scores) in the Animate-Random contrast for clusters significantly predicted by OT (clusters from
Table 1B), plotted against OT levels to illustrate a positive association. Variation in cluster color represents independent clusters.
we did not manipulate attention in our task, the brain activity
in regions predicted by OT levels parallels results from the
condition in Tavares et al. (2008) in which attention was directed
to social aspects of the stimuli (i.e., greater activation in TPJ, STS,
dmPFC). This suggests that participants with higher endogenous
OT levels are naturally attending to the more social aspects of the
task. Broadly, we believe these results demonstrate that natural
variations in OT levels may predict an individual’s sensitivity to
social information.
These results have several implications for the existing OT
administration literature. For one, our findings may help us to
interpret some of the prior conflicting findings arising from
intranasal OT administration. While plasma levels of OT have
largely been ignored in administration studies, it has been
previously speculated that exogenous OT administration may
interact with endogenous levels to influence behavior (Bartz
et al., 2011). Prior work has shown that OT effects may be dose-
dependent (Cardoso et al., 2013), and non-linear (Zhong et al.,
2012). Our own sample of healthy, young, male subjects showed
considerable variability in plasma OT levels--so much so that we
excluded 3 outliers from our relatively small sample. It is not clear
that exogenous administration will similarly impact individuals
when such high variability in endogenous levels of OT exists.
Our finding that these levels have functional significance suggests
that OT plasma levels are tonic individual differences that should
be measured and considered in relation to pharmacological
manipulations.
Our study comes with several caveats. As with any proof-
of-concept study, a number of questions remain unanswered.
First, like many other OT studies, our sample consists solely
of male subjects. This is problematic since sex differences in
the effects of OT administration on social cognition have been
observed (Domes et al., 2010), potentially due to interactions
with female sex steroids (McCarthy and Pfaus, 1996). Further,
plasma OT levels may vary as a function of the menstrual cycle,
with luteal phase decreases that are not observed in women
taking oral contraceptives (Salonia et al., 2005). For these reasons,
OT studies involving women participants should be optimized to
control for variations in menstrual cycle status and conceptive
use. In the context of the current work, it is unclear whether
we would expect sex-differences in our simple, non-valenced
task; an OT administration study with a similar task (perception
of biological motion) did not find sex differences (Kéri and
Benedek, 2009), nor are sex differences usually reported more
broadly for this task. Thus, we have no direct predictions about
sex effects and hope these will be empirically investigated in the
future, despite the difficulties in properly assessing plasma OT in
women.
Another issue concerns the relationship between peripheral
(plasma) OT and central OT. Because endogenous OT cannot
cross the blood-brain barrier, it is unclear how well plasma
levels are associated with levels in the CNS; peripheral levels
are regulated by the posterior pituitary, while central levels
are regulated by nuclei within the hypothalamus (Neumann,
2008). The evidence on their association is mixed, with some
animal models showing little association between plasma OT
and OT levels in CSF (Winslow et al., 2003), while others show
coordinated release of OT both peripherally and in the supraoptic
nucleus of the hypothalamus (Landgraf and Neumann, 2004).
However, questions of mechanism are not limited to plasma
OT studies; research involving intranasally administered OT has
similar mechanistic gaps. In fact, it had not been shown until
recently that intranasally administered OT is taken up by the
brain (Neumann et al., 2013). Moreover, the particular route
through which intranasally administered OT reaches the brain
has not been conclusively identified (Evans et al., 2014). The
association between OT--whether observed or manipulated--and
behavior is ultimately the most important piece of evidence for
its neuromodulatory role.
In conclusion, we present initial evidence that plasma OT
levels are significant predictors of individual differences in neural
response to social stimuli. While the importance of OT for social
cognition and behavior has been demonstrated in a number of
exogenous administration studies, presumably these effects are
meaningful only insofar that they can be shown to occur within
the naturally-occurring variability in endogenous levels of OT.
We are the first to show this at the neural level. Specifically, we
show that plasma OT levels are strongly, positively associated
with activity in the brain’s centers for social cognitive processing.
Given that endogenous OT levels vary substantially between
people and are stable over time, plasma OT could serve
as a biological indicator of sensitivity to social information.
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Further study of endogenous OT may provide insight into
the biological mechanisms underlying individual differences in
this domain.
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